Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to…
Diabetes
Hiltzik: Why health insurers won’t pay for these miracle weight-loss drugs
It’s rare — miraculously rare — that a drug can have such a pronounced effect that…
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations
The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications…
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter
INDIANAPOLIS — Eli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight…